CTSO
Cytosorbents Crp
4.10$
-3.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 40.5% | 48.3% | 42.5% | 41.1% | 34.7% | 45.6% | 50.0% | 47.9% | 46.6% | 46.7% | 43.8% | 41.5% | |
| 17.6% | 26.5% | 18.3% | 15.8% | 11.9% | 6.9% | 22.8% | 21.3% | 16.5% | 14.1% | 11.9% | 11.6% | |
| 17.6% | 26.5% | 18.3% | 15.8% | 11.9% | 6.9% | 22.8% | 21.3% | 16.5% | 14.1% | 11.9% | 11.6% | |
| 13.0% | 11.4% | 14.4% | 14.6% | 13.9% | 15.5% | 15.1% | 16.1% | 16.2% | 17.1% | 17.6% | 17.9% | |
| 6.3% | 6.9% | 7.9% | 8.1% | 6.8% | 5.8% | 5.9% | 7.7% | 8.7% | 12.0% | 11.0% | 9.7% | |
| – | – | – | – | – | – | – | – | – | 7.3% | – | – | |
| – | 7.3% | – | – | – | 7.9% | 7.3% | 7.8% | 7.9% | 7.3% | 7.3% | 7.5% | |
| 61.1% | 56.3% | 59.8% | 68.7% | 72.8% | 76.6% | 71.4% | 75.9% | 80.3% | 86.6% | 94.6% | 102.0% | |
| 25.2% | 27.3% | 28.5% | 19.3% | 17.6% | 20.7% | 19.2% | 20.5% | 22.1% | 22.0% | 40.2% | 63.3% | |
| 2.0% | 5.4% | 6.1% | 0.8% | 0.9% | 1.0% | 0.9% | 1.0% | 1.1% | 1.2% | 17.8% | 38.8% | |
| 7.2% | 7.1% | 5.1% | 5.7% | 4.9% | 7.1% | 6.5% | 7.1% | 6.6% | 6.5% | 7.7% | 5.3% | |
| 8.8% | 4.8% | 4.1% | 25.6% | 28.9% | 29.5% | 27.9% | 30.0% | 31.8% | 37.7% | 25.4% | 8.1% | |
| 38.9% | 43.7% | 40.2% | 31.3% | 27.2% | 23.4% | 28.6% | 24.1% | 19.7% | 13.4% | 5.4% | -2.0% | |
| -581.5% | -530.4% | -613.7% | -548.4% | -617.8% | -641.8% | -601.6% | -632.5% | -670.4% | -706.6% | -782.3% | -847.6% | |
| 4.7% | 4.2% | 5.8% | 5.1% | 5.7% | 5.8% | 6.0% | 7.0% | 6.9% | 7.1% | 7.7% | 8.3% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.